Modelling of drug disposition kinetics in in vitro intestinal absorption cell models.
暂无分享,去创建一个
[1] G. Koren,et al. Modeling of P-glycoprotein-involved epithelial drug transport in MDCK cells. , 1999, American journal of physiology. Renal physiology.
[2] P. Artursson,et al. Regional levels of drug transporters along the human intestinal tract: co-expression of ABC and SLC transporters and comparison with Caco-2 cells. , 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[3] K. Pang,et al. Influence of P-glycoprotein, transfer clearances, and drug binding on intestinal metabolism in Caco-2 cell monolayers or membrane preparations: a theoretical analysis. , 2003, Drug metabolism and disposition: the biological fate of chemicals.
[4] K. Luthman,et al. Effect of molecular charge on intestinal epithelial drug transport: pH-dependent transport of cationic drugs. , 1999, The Journal of pharmacology and experimental therapeutics.
[5] Lawrence X. Yu,et al. Mechanistic Approaches to Predicting Oral Drug Absorption , 2009, The AAPS Journal.
[6] Christos Reppas,et al. Dissolution Testing as a Prognostic Tool for Oral Drug Absorption: Immediate Release Dosage Forms , 2004, Pharmaceutical Research.
[7] D. Thakker,et al. Efflux Ratio Cannot Assess P-Glycoprotein-Mediated Attenuation of Absorptive Transport: Asymmetric Effect of P-Glycoprotein on Absorptive and Secretory Transport Across Caco-2 Cell Monolayers , 2003, Pharmaceutical Research.
[8] G L Amidon,et al. A compartmental absorption and transit model for estimating oral drug absorption. , 1999, International journal of pharmaceutics.
[9] Matthew D. Troutman,et al. Novel Experimental Parameters to Quantify the Modulation of Absorptive and Secretory Transport of Compounds by P-Glycoprotein in Cell Culture Models of Intestinal Epithelium , 2003, Pharmaceutical Research.
[10] K. Luthman,et al. Caco-2 monolayers in experimental and theoretical predictions of drug transport. , 2001, Advanced drug delivery reviews.
[11] S. Chong,et al. Cell culture-based models for intestinal permeability: a critique. , 2005, Drug discovery today.
[12] P. Artursson,et al. Caco-2 permeability of weakly basic drugs predicted with the double-sink PAMPA pKa(flux) method. , 2005, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[13] K. Sandy Pang,et al. Response to Letter to the Editor on “Permeability, Transport, and Metabolism of Solutes in Caco-2 Cell Monolayers: A Theoretical Study” , 2010, Drug Metabolism and Disposition.
[14] C. Anthony Hunt,et al. Mechanistic simulations explain paradoxical saquinavir metabolism during in vitro vectorial transport study , 2009 .
[15] Nipa Shah,et al. Biopharmaceutics classification system: validation and learnings of an in vitro permeability assay. , 2009, Molecular pharmaceutics.
[16] Thomas J. Raub,et al. Passive diffusion of weak organic electrolytes across Caco-2 cell monolayers: uncoupling the contributions of hydrodynamic, transcellular, and paracellular barriers. , 1995, Journal of pharmaceutical sciences.
[17] A. Galetin,et al. Methodology for development of a physiological model incorporating CYP3A and P-glycoprotein for the prediction of intestinal drug absorption. , 2009, Journal of pharmaceutical sciences.
[18] Per Artursson,et al. Caco-2 permeability of weakly basic drugs predicted with the Double-Sink PAMPA method , 2005 .
[19] C Anthony Hunt,et al. Studies of intestinal drug transport using an in silico epithelio-mimetic device. , 2005, Bio Systems.
[20] J. Mönkkönen,et al. In vitro-in vivo correlation in P-glycoprotein mediated transport in intestinal absorption. , 2009, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[21] Kristina Luthman,et al. Caco-2 monolayers in experimental and theoretical predictions of drug transport1PII of original article: S0169-409X(96)00415-2. The article was originally published in Advanced Drug Delivery Reviews 22 (1996) 67–84.1 , 2001 .
[22] J. Polli,et al. The Steady-State Michaelis–Menten Analysis of P-Glycoprotein Mediated Transport Through a Confluent Cell Monolayer Cannot Predict the Correct Michaelis Constant Km , 2005, Pharmaceutical Research.
[23] R. Toral,et al. Drug absorption through a cell monolayer: a theoretical work on a non-linear three-compartment model. , 2008, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[24] Michael B. Bolger,et al. Simulations of the Nonlinear Dose Dependence for Substrates of Influx and Efflux Transporters in the Human Intestine , 2009, The AAPS Journal.
[25] Ismael Zamora,et al. pH-Dependent Bidirectional Transport of Weakly Basic Drugs Across Caco-2 Monolayers: Implications for Drug–Drug Interactions , 2003, Pharmaceutical Research.
[26] Kerby Shedden,et al. A cell-based molecular transport simulator for pharmacokinetic prediction and cheminformatic exploration. , 2006, Molecular pharmaceutics.
[27] Marjo Yliperttula,et al. Passive oral drug absorption can be predicted more reliably by experimental than computational models--fact or myth. , 2008, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[28] T. Henzinger,et al. Executable cell biology , 2007, Nature Biotechnology.
[29] Z. Zuo,et al. A Catenary Model to Study Transport and Conjugation of Baicalein, a Bioactive Flavonoid, in the Caco-2 Cell Monolayer: Demonstration of Substrate Inhibition , 2008, Journal of Pharmacology and Experimental Therapeutics.
[30] P. van Hoogevest,et al. Absorption of poorly water soluble drugs subject to apical efflux using phospholipids as solubilizers in the Caco-2 cell model. , 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[31] Michael B. Bolger,et al. In Silico Modeling of Non-Linear Drug Absorption for the P-gp Substrate Talinolol and of Consequences for the Resulting Pharmacodynamic Effect , 2006, Pharmaceutical Research.
[32] H. Lennernäs,et al. Gene and protein expression of P-glycoprotein, MRP1, MRP2, and CYP3A4 in the small and large human intestine. , 2007, Molecular pharmaceutics.
[33] U. Fagerholm. Prediction of human pharmacokinetics —gastrointestinal absorption , 2007, The Journal of pharmacy and pharmacology.
[34] P. Artursson,et al. Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers , 2007, Nature Protocols.
[35] J. Polli,et al. Rational use of in vitro P-glycoprotein assays in drug discovery. , 2001, The Journal of pharmacology and experimental therapeutics.
[36] M. Jamei,et al. A framework for assessing inter-individual variability in pharmacokinetics using virtual human populations and integrating general knowledge of physical chemistry, biology, anatomy, physiology and genetics: A tale of 'bottom-up' vs 'top-down' recognition of covariates. , 2009, Drug metabolism and pharmacokinetics.
[37] K. Luthman,et al. Caco-2 monolayers in experimental and theoretical predictions of drug transport , 1996 .
[38] J. Polli,et al. The elementary mass action rate constants of P-gp transport for a confluent monolayer of MDCKII-hMDR1 cells. , 2005, Biophysical journal.
[39] G. Amidon,et al. Human Intestinal Permeability of Piroxicam, Propranolol, Phenylalanine, and PEG 400 Determined by Jejunal Perfusion , 1997, Pharmaceutical Research.
[40] Ulf Norinder,et al. Exploring the role of different drug transport routes in permeability screening. , 2005, Journal of medicinal chemistry.
[41] P. Artursson,et al. A method for the determination of cellular permeability coefficients and aqueous boundary layer thickness in monolayers of intestinal epithelial caco 2 cells grown in permeable filter chambers , 1991 .
[42] G. M. Pollack,et al. Intestinal Absorptive Transport of the Hydrophilic Cation Ranitidine: A Kinetic Modeling Approach to Elucidate the Role of Uptake and Efflux Transporters and Paracellular vs. Transcellular Transport in Caco-2 Cells , 2006, Pharmaceutical Research.
[43] J. Polli,et al. Bias in Estimation of Transporter Kinetic Parameters from Overexpression Systems: Interplay of Transporter Expression Level and Substrate Affinity , 2007, Journal of Pharmacology and Experimental Therapeutics.
[44] M. Zeidel,et al. The relationship between membrane fluidity and permeabilities to water, solutes, ammonia, and protons , 1995, The Journal of general physiology.
[45] J. Mönkkönen,et al. Analysis of unstirred water layer in in vitro permeability experiments. , 2009, Journal of pharmaceutical sciences.
[46] G. M. Pollack,et al. Kinetic Considerations for the Quantitative Assessment of Efflux Activity and Inhibition: Implications for Understanding and Predicting the Effects of Efflux Inhibition , 2007, Pharmaceutical Research.
[47] J. Mönkkönen,et al. Kinetics of Cellular Retention during Caco-2 Permeation Experiments: Role of Lysosomal Sequestration and Impact on Permeability Estimates , 2009, Journal of Pharmacology and Experimental Therapeutics.
[48] Mei-Ling Chen,et al. Summary workshop report: biopharmaceutics classification system--implementation challenges and extension opportunities. , 2004, Journal of pharmaceutical sciences.
[49] M. Bermejo,et al. Kinetic modelling of passive transport and active efflux of a fluoroquinolone across Caco-2 cells using a compartmental approach in NONMEM , 2005, Xenobiotica; the fate of foreign compounds in biological systems.
[50] Lana X Garmire,et al. In Silico Methods for Unraveling the Mechanistic Complexities of Intestinal Absorption: Metabolism-Efflux Transport Interactions , 2008, Drug Metabolism and Disposition.
[51] Aditya Mittal,et al. Exact kinetic analysis of passive transport across a polarized confluent MDCK cell monolayer modeled as a single barrier. , 2004, Journal of pharmaceutical sciences.
[52] J. Mönkkönen,et al. Decrease in Intracellular Concentration Causes the Shift in Km Value of Efflux Pump Substrates , 2007, Drug Metabolism and Disposition.
[53] Sebastian Polak,et al. Population-Based Mechanistic Prediction of Oral Drug Absorption , 2009, The AAPS Journal.
[54] J. Mönkkönen,et al. The Asymmetry of the Unstirred Water Layer in Permeability Experiments , 2008, Pharmaceutical Research.